Bodenstedt Matthias

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bodenstedt Matthias's trades of MoonLake Immunotherapeutics's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-22
PlS Planned sale
42,782 -10.9%
351.21
US$1,130,914 		42,782 -10.9% 351.21 US$1,130,914
2026-06-18 2026-06-18
PlS Planned sale
92,021 -31.7%
208.17
US$1,224,758 		92,021 -31.7% 208.17 US$1,224,758
2026-06-18 2026-06-17
PlS Planned sale
59,252 -41.8%
251.81
US$2,874,093 		59,252 -41.8% 251.81 US$2,874,093
2026-05-13 2026-05-11
PlS Planned sale
13,653 -1.2%
20.02
US$273,333 		13,653 -1.2% 20.02 US$273,333
2026-04-16 2026-04-14
PlS Planned sale
2,426 -0.2%
19.56
US$47,453 		2,426 -0.2% 19.56 US$47,453
2026-04-10 2026-04-10
PlS Planned sale
1,925 -0.2%
19.51
US$37,557 		1,925 -0.2% 19.51 US$37,557
2026-04-10 2026-04-09
PlS Planned sale
85,870 -6.7%
18.94
US$1,626,378 		85,870 -6.7% 18.94 US$1,626,378
2026-04-09 2026-04-09
PrS Proposed sale
160,870
18.46
US$2,969,660 		160,870 18.46 US$2,969,660
2025-10-09 2025-10-08
B Purchase
10,870 +1.8%
9.09
US$98,808 		10,870 +1.8% 9.09 US$98,808
2023-12-21 2023-12-20
PlS Planned sale
5,264 -1.0%
58.34
US$307,102 		5,264 -1.0% 58.34 US$307,102
2023-12-20 2023-12-20
PrS Proposed sale
5,264
59.27
US$311,997 		5,264 59.27 US$311,997
2023-12-21 2023-12-19
PlS Planned sale
94,736 -15.3%
59.22
US$5,610,266 		94,736 -15.3% 59.22 US$5,610,266
2023-12-19 2023-12-19
PrS Proposed sale
94,736
59.22
US$5,610,266 		94,736 59.22 US$5,610,266